These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 10719950)

  • 1. Effect of edrophonium and neostigmine on the pharmacokinetics and neuromuscular effects of mivacurium.
    Szenohradszky J; Fogarty D; Kirkegaard-Nielsen H; Brown R; Sharma ML; Fisher DM
    Anesthesiology; 2000 Mar; 92(3):708-14. PubMed ID: 10719950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The reversal of profound mivacurium-induced neuromuscular blockade.
    Kao YJ; Le ND
    Can J Anaesth; 1996 Nov; 43(11):1128-33. PubMed ID: 8922768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonism of mivacurium neuromuscular block: neostigmine versus edrophonium.
    Devcic A; Munshi CA; Gandhi SK; Kampine JP
    Anesth Analg; 1995 Nov; 81(5):1005-9. PubMed ID: 7486038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of neostigmine on twitch tension and muscle relaxant concentration during infusion of mivacurium or vecuronium.
    Szenohradszky J; Lau M; Brown R; Sharma ML; Fisher DM
    Anesthesiology; 1995 Jul; 83(1):83-7. PubMed ID: 7605023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neostigmine but not edrophonium prolongs the action of mivacurium.
    Symington MJ; Mirakhur RK; Kumar N
    Can J Anaesth; 1996 Dec; 43(12):1220-3. PubMed ID: 8955970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholinesterase inhibitors do not prolong neuromuscular block produced by mivacurium.
    Fleming NW; Lewis BK
    Br J Anaesth; 1994 Aug; 73(2):241-3. PubMed ID: 7917744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism of mivacurium-induced neuromuscular blockade in humans. Edrophonium dose requirements at threshold train-of-four count of 4.
    Kopman AF; Mallhi MU; Justo MD; Rodricks P; Neuman GG
    Anesthesiology; 1994 Dec; 81(6):1394-400. PubMed ID: 7992908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose responses for neostigmine and edrophonium as antagonists of mivacurium in adults and children.
    Bevan JC; Tousignant C; Stephenson C; Blackman L; Reimer E; Smith MF; Bevan DR
    Anesthesiology; 1996 Feb; 84(2):354-61. PubMed ID: 8602666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-response relationships for edrophonium and neostigmine antagonism of mivacurium-induced neuromuscular block.
    Naguib M; Abdulatif M; al-Ghamdi A; Hamo I; Nouheid R
    Br J Anaesth; 1993 Nov; 71(5):709-14. PubMed ID: 8251285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of edrophonium and neostigmine for the reversal of mivacurium-induced neuromuscular blockade in sheep.
    Clutton RE; Glasby MA
    Res Vet Sci; 1998; 64(3):265-6. PubMed ID: 9690616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Edrophonium increases mivacurium concentrations during constant mivacurium infusion, and large doses minimally antagonize paralysis.
    Hart PS; Wright PM; Brown R; Lau M; Sharma ML; Miller RD; Gruenke L; Fisher DM
    Anesthesiology; 1995 Apr; 82(4):912-8. PubMed ID: 7717563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neostigmine and edrophonium. Antagonism of profound and shallow mivacurium blockade].
    Bartunek A; Gilly H; Huemer G; Yildiz S; Schramm W; Lackner FX; Foldes FF
    Anaesthesist; 1997 Feb; 46(2):96-100. PubMed ID: 9133184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of mivacurium chloride: edrophonium of spontaneous recovery in microscopic laryngeal surgery.
    Ting CK; Lin SM; Yang YW; Tsai HJ; Lao HC; Chu YC; Tsai SK
    Acta Anaesthesiol Sin; 2001 Dec; 39(4):157-62. PubMed ID: 11840581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacokinetics and steady state pharmacodynamics of mivacurium in children.
    Markakis DA; Lau M; Brown R; Luks AM; Sharma ML; Fisher DM
    Anesthesiology; 1998 Apr; 88(4):978-83. PubMed ID: 9579507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamics and the plasma concentration of mivacurium during spontaneous recovery and neostigmine-facilitated recovery.
    Lien CA; Belmont MR; Wray Roth DL; Okamoto M; Abalos A; Savarese JJ
    Anesthesiology; 1999 Jul; 91(1):119-26. PubMed ID: 10422936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery from mivacurium block with or without anticholinesterase following continuous infusion in obstetric patients.
    Jan GS; Tong WN; Chan AM; Hui TW; Lo JW
    Anaesth Intensive Care; 1996 Oct; 24(5):585-9. PubMed ID: 8909671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery of mivacurium block with or without anticholinesterases following administration by continuous infusion.
    Maddineni VR; Mirakhur RK; McCoy EP
    Anaesthesia; 1994 Nov; 49(11):946-8. PubMed ID: 7802237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Edrophonium and human plasma cholinesterase combination for antagonism of mivacurium-induced neuromuscular block.
    Naguib M; Samarkandi AH; Bakhamees HS; Turkistani A; Alharby SW
    Br J Anaesth; 1996 Sep; 77(3):424-6. PubMed ID: 8949825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of different doses of edrophonium antagonism of mivacurium-induced neuromuscular block in the presence of nitrous oxide, propofol, and alfentanil anesthesia].
    Ripart J; Drolet P; Perreault L; Girard M
    Can J Anaesth; 1996 Apr; 43(4):368-72. PubMed ID: 8697552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Edrophonium requirements for reversal of deep neuromuscular block following infusion of mivacurium.
    Miller DR; Bryson G; Martineau RJ; Kitts JB; Curran M; Bragg P; Watson JB; Hull K; Lindsay P
    Can J Anaesth; 1995 Nov; 42(11):996-1002. PubMed ID: 8590511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.